# Non-invasive Biomarkers of Metabolic Liver Disease (NIMBLE) Study 1.2

> **NCT05081427** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 17 (actual)

## Conditions studied

- Nonalcoholic Fatty Liver

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05081427
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-15
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2022-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05081427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05081427, "Non-invasive Biomarkers of Metabolic Liver Disease (NIMBLE) Study 1.2". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05081427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*